Sugi Predict

Sugi Predict / Compounds / SCHEMBL1504764

SCHEMBL1504764

SCHEMBL1504764

O=C(Nc1cc[nH]n1)c1ccc(Br)c(NC(=O)c2ccc(=O)n(-c3c(F)cccc3F)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 2/20 0.39
▸ HDAC8 Q9BY41 2/20 0.39
▸ HDAC6 Q9UBN7 2/20 0.39
▸ BCHE P06276 1/20 0.35
▸ RAB9A P51151 7/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ GAA P10253 3/20 0.34
▸ HTT P42858 1/20 0.34
▸ NPC1 O15118 3/20 0.34
▸ F10 P00742 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RECQL P46063 1/20 0.34
▸ CASP6 P55212 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ TP53 P04637 1/20 0.34
▸ MAPK14 Q16539 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1504576 0.89 MAPK14 (0.41) HDAC1HDAC8HDAC6MEN1KMT2A
SCHEMBL1504662 0.83 MAPK14 (0.47) HDAC1HDAC8HDAC6RAB9AMEN1
SCHEMBL1504699 0.83 HDAC1 (0.46) HDAC1HDAC8HDAC6BCHERAB9A
SCHEMBL1504668 0.83 HDAC1 (0.42) HDAC1HDAC8HDAC6BCHERAB9A
SCHEMBL1504645 0.83 NPC1 (0.47) HDAC1HDAC8HDAC6BCHERAB9A
SCHEMBL1504566 0.82 HDAC1 (0.49) HDAC1HDAC8HDAC6BCHERAB9A
SCHEMBL1504789 0.80 MAPK14 (0.47) HDAC1HDAC8HDAC6KMT2AMAPK14
SCHEMBL1504763 0.80 CYP11B1 (0.52) MEN1KMT2AALDH1A1GAANPC1
SCHEMBL1504703 0.79 MAPK14 (0.47) HDAC1HDAC8HDAC6BCHERAB9A
SCHEMBL1504594 0.78 KDM4E (0.46) HDAC1HDAC8HDAC6BCHERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173684-B2 Pyridone derivatives as p38α MAPK inhibitors ASTELLAS PHARMA INC. (JP) 2012-05-08 — — US disclosed
US-8173684-B2 Pyridone derivatives as p38α MAPK inhibitors ASTELLAS PHARMA INC. (JP) 2012-05-08 — — US disclosed
US-8173684-B2 Pyridone derivatives as p38α MAPK inhibitors ASTELLAS PHARMA INC. (JP) 2012-05-08 — — US disclosed
EP-2155683-B1 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS ASTELLAS PHARMA INC (JP) 2011-03-16 — — EP disclosed
US-20100063098-A1 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS ASTELLAS PHARMA INC. (JP) 2010-03-11 — — US disclosed
US-20100063098-A1 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS ASTELLAS PHARMA INC. (JP) 2010-03-11 — — US disclosed
US-20100063098-A1 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS ASTELLAS PHARMA INC. (JP) 2010-03-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063098-A1 PYRIDONE DERIVATIVES AS P38A MAPK INHIBITORS MAPK1, MAPK6, MAPK3 HDAC1 777/4885HDAC8 1531/4885HDAC6 2198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.